Cargando…
Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments
Late-phase clinical trials within diabetes generally have a duration of 12–24 weeks, where 12 weeks may be too short to reach steady-state glycated hemoglobin (HbA1c). The main determinant for HbA1c is blood glucose, which reaches steady state much sooner. In spite of this, few publications have use...
Autores principales: | Møller, J B, Overgaard, R V, Kjellsson, M C, Kristensen, N R, Klim, S, Ingwersen, S H, Karlsson, M O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817378/ https://www.ncbi.nlm.nih.gov/pubmed/24172651 http://dx.doi.org/10.1038/psp.2013.58 |
Ejemplares similares
-
Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches
por: Møller, JB, et al.
Publicado: (2016) -
Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches
por: Møller, J B, et al.
Publicado: (2014) -
The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model
por: Røge, RM, et al.
Publicado: (2015) -
Weight‐HbA1c‐insulin‐glucose model for describing disease progression of type 2 diabetes
por: Choy, S, et al.
Publicado: (2015) -
Comparison of Power, Prognosis, and Extrapolation Properties of Four Population Pharmacodynamic Models of HbA1c for Type 2 Diabetes
por: Wellhagen, Gustaf J., et al.
Publicado: (2018)